Search

Your search keyword '"Ruxrungtham Kiat"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Ruxrungtham Kiat" Remove constraint Author: "Ruxrungtham Kiat" Publisher elsevier bv Remove constraint Publisher: elsevier bv
Sorry, I don't understand your search. ×
59 results on '"Ruxrungtham Kiat"'

Search Results

1. From private incentives to public health need: rethinking research and development for pandemic preparedness

4. It is time for ambitious, transformational change to the epidemic countermeasures ecosystem

5. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

7. IL-10–producing innate lymphoid cells increased in patients with house dust mite allergic rhinitis following immunotherapy

9. Performance of a simple flow cytometric assay in diagnosing active tuberculosis

10. Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 ​cells/mm3 in Thailand

11. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

12. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

13. Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand

14. Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy

15. Influenza Immunoglobulin for Adults Hospitalized with Influenza

16. Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program

17. Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract

20. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

21. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

22. The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014

24. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults

25. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network

29. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial

30. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

32. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

34. HLA-DRB1454 and predictors of new-onset asthma in HIV-infected Thai children

35. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

42. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial

43. A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays

46. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

47. Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age

48. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

49. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors

Catalog

Books, media, physical & digital resources